Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.

Huang MM, Driscoll CB, Handa N, Wahba BM, Laviana AA, Patel HD, Jalali A, Hu JC, Schaeffer EM

Open source

DOI
10.1002/cncr.70118
Published
2025 Nov 1
Container
Cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cncr.70118,
  title = {Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.},
  author = {Huang MM and Driscoll CB and Handa N and Wahba BM and Laviana AA and Patel HD and Jalali A and Hu JC and Schaeffer EM},
  year = {2025},
  journal = {Cancer},
  doi = {10.1002/cncr.70118},
  url = {https://doi.org/10.1002/cncr.70118}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.
AU  - Huang MM
AU  - Driscoll CB
AU  - Handa N
AU  - Wahba BM
AU  - Laviana AA
AU  - Patel HD
AU  - Jalali A
AU  - Hu JC
AU  - Schaeffer EM
PY  - 2025
JO  - Cancer
DO  - 10.1002/cncr.70118
UR  - https://doi.org/10.1002/cncr.70118
ER  - 

APA

MM, H., CB, D., N, H., BM, W., AA, L., HD, P., A, J., JC, H., & EM, S. (2025). Cost-effectiveness of office-based, magnetic resonance imaging-guided transperineal versus transrectal prostate biopsy: An economic analysis of the PREVENT trial.. Cancer. https://doi.org/10.1002/cncr.70118

Source records